UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 137

Sortiert nach

Oral anticoagulation in very elderly patients with atrial fibrillation: Results from the prospective multicenter START2-REGISTER study

PloS one, 2019-05, Vol.14 (5), p.e0216831-e0216831

2019

Link zum Volltext

Verfügbarkeit prüfen

Bleeding Risk During Oral Anticoagulation in Atrial Fibrillation Patients Older Than 80 Years

Journal of the American College of Cardiology, 2009-09, Vol.54 (11), p.999-1002

2009

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology, diagnosis, and management of atrial fibrillation in women

International journal of women's health, 2015-01, Vol.7, p.605-614

2015

Link zum Volltext

Verfügbarkeit prüfen

Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry

PloS one, 2019-07, Vol.14 (7), p.e0219676-e0219676

2019

Link zum Volltext

Verfügbarkeit prüfen

Low platelet count at admission has an adverse impact on outcome in patients with acute coronary syndromes: from the START Antiplatelet registry

Scientific reports, 2024-06, Vol.14 (1), p.14516-10, Article 14516

2024

Link zum Volltext

Verfügbarkeit prüfen

Bleeding and mortality risk in patients implanted with mechanical prosthetic heart valves with and without thrombocytopenia. Insights from the nationwide PLECTRUM registry

Platelets (Edinburgh), 2022-10, Vol.33 (7), p.1018-1023

2022

Link zum Volltext

Verfügbarkeit prüfen

Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register

Therapeutic advances in drug safety, 2021-12, Vol.12, p.20420986211062965-20420986211062965

2021

Link zum Volltext

Verfügbarkeit prüfen

Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment

Thrombosis and haemostasis, 2009-05, Vol.101 (5), p.938

2009

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome

PloS one, 2017-10, Vol.12 (10), p.e0186961

2017

Link zum Volltext

Verfügbarkeit prüfen

Stroke Risk Stratification in a "Real-World" Elderly Anticoagulated Atrial Fibrillation Population

Journal of cardiovascular electrophysiology, 2011-01, Vol.22 (1), p.25-30

2011

Link zum Volltext

Verfügbarkeit prüfen

Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry

Internal and emergency medicine, 2021-03, Vol.16 (2), p.379-387

2021

Link zum Volltext

Verfügbarkeit prüfen

Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolism

Journal of thrombosis and thrombolysis, 2010-10, Vol.30 (3), p.294-299

2010

Link zum Volltext

Verfügbarkeit prüfen

p-Coumaric acid, a common dietary phenol, inhibits platelet activity in vitro and in vivo

British journal of nutrition, 2007-03, Vol.97 (3), p.458-463

2007

Link zum Volltext

Verfügbarkeit prüfen

Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry

Journal of the American Heart Association, 2019-11, Vol.8 (21), p.e012596-e012596

2019

Link zum Volltext

Verfügbarkeit prüfen

Treatment Decision-Making of Secondary Prevention After Venous Thromboembolism: Data From the Real-Life START2-POST-VTE Register

Clinical and applied thrombosis/hemostasis, 2020, Vol.26, p.107602962094579-1076029620945792

2020

Link zum Volltext

Verfügbarkeit prüfen

Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome

Internal and emergency medicine, 2021-09, Vol.16 (6), p.1583-1591

2021

Link zum Volltext

Verfügbarkeit prüfen

Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register

BMJ open, 2020-11, Vol.10 (11), p.e040449

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients

Thrombosis and haemostasis, 2010-08, Vol.104 (2), p.287

2010

Link zum Volltext

Verfügbarkeit prüfen

Clinical Phenotypes of Atrial Fibrillation and Mortality Risk-A Cluster Analysis from the Nationwide Italian START Registry

Journal of personalized medicine, 2022-05, Vol.12 (5), p.785

2022

Link zum Volltext

Verfügbarkeit prüfen

Design and rationale of a randomized, placebo-controlled trial on the efficacy and safety of sulodexide for extended treatment in elderly patients after a first venous thromboembolism

Internal and emergency medicine, 2021-03, Vol.16 (2), p.359-368

2021

Link zum Volltext

Verfügbarkeit prüfen

Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention

Thrombosis and haemostasis, 2009-02, Vol.101 (2), p.367

2009

Link zum Volltext

Verfügbarkeit prüfen

Inappropriate Underdosing of Direct Oral Anticoagulants in Atrial Fibrillation Patients: Results from the START2-AF Registry

Journal of clinical medicine, 2024-04, Vol.13 (7), p.2009

2024

Link zum Volltext

Verfügbarkeit prüfen

D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study

Internal and emergency medicine, 2020-04, Vol.15 (3), p.453-462

2020

Link zum Volltext

Verfügbarkeit prüfen

Management and Outcomes of Isolated Distal Deep Vein Thromboses: A Questionable Trend toward Long-Lasting Anticoagulation Treatment. Results from the START-Register

TH open : companion journal to thrombosis and haemostasis, 2021-07, Vol.5 (3), p.e239-e250

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 137

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(112)

Publikationsform

Artikel
(136)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Oral anticoagulation in very elderly patients with atrial fibrillation: Results from the prospective multicenter START2-REGISTER study

Bleeding Risk During Oral Anticoagulation in Atrial Fibrillation Patients Older Than 80 Years

Epidemiology, diagnosis, and management of atrial fibrillation in women

Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry

Low platelet count at admission has an adverse impact on outcome in patients with acute coronary syndromes: from the START Antiplatelet registry

Bleeding and mortality risk in patients implanted with mechanical prosthetic heart valves with and without thrombocytopenia. Insights from the nationwide PLECTRUM registry

Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register

Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment

Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome

Stroke Risk Stratification in a "Real-World" Elderly Anticoagulated Atrial Fibrillation Population

Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry

Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension in patients after a first episode of pulmonary embolism

p-Coumaric acid, a common dietary phenol, inhibits platelet activity in vitro and in vivo

Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry

Treatment Decision-Making of Secondary Prevention After Venous Thromboembolism: Data From the Real-Life START2-POST-VTE Register

Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome

Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register

Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients

Clinical Phenotypes of Atrial Fibrillation and Mortality Risk-A Cluster Analysis from the Nationwide Italian START Registry

Design and rationale of a randomized, placebo-controlled trial on the efficacy and safety of sulodexide for extended treatment in elderly patients after a first venous thromboembolism

Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention

Inappropriate Underdosing of Direct Oral Anticoagulants in Atrial Fibrillation Patients: Results from the START2-AF Registry

Long-Term Outcomes in Two-Year Follow-Up after Primary Treatment in Patients with a Prior Venous Thromboembolic Event: A Prospective, Observational, Real-Life Study

D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study

Management and Outcomes of Isolated Distal Deep Vein Thromboses: A Questionable Trend toward Long-Lasting Anticoagulation Treatment. Results from the START-Register

Suchergebnisse filtern